NRIX · US market
NURIX THERAPEUTICS INC COM
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$2.42bnFinancials dated 31 May 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$341.35m
- Latest-quarter run-rate earnings
- -US$358.14m
- Latest fiscal-year earnings
- -US$264.46m
- Trailing revenue
- US$36.77m
- Latest-quarter run-rate revenue
- US$36.17m
- Latest fiscal-year revenue
- US$83.98m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- ARKG.L · ARK Genomic Revolution UCITS ETF2.86% weight · Holdings dated 3 August 2026
- ARKG · ARK Genomic Revolution ETF2.33% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- HEAL · Global X HealthTech ETF1.62% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF0.60% weight · Holdings dated 21 August 2026
- IWC · iShares Micro-Cap ETF0.58% weight · Holdings dated 21 August 2026
- FYC · First Trust Small Cap Growth AlphaDEX® Fund0.35% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FSSLX · Fidelity Series Small Cap Core Fund0.25% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- TSMEX · TIAA-CREF Quant Small/Mid-Cap Equity Fund Retail Class0.20% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- VSTCX · Vanguard Strategic Small-Cap Equity Fund0.20% weight · Holdings dated 30 June 2026
- IBB · iShares Biotechnology ETF0.19% weight · Holdings dated 19 August 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 May 2026. Informational research, not investment advice.